Nova Patents
IL250080B

Methods for treating patients with heterozygous familial hypercholesterolemia (hefh)

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

38 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
62025362United States of America–
62043144United States of America–
62080717United States of America–
153054192European Patent Office (EPO)–

Members38

Family members, oldest first
DocumentOfficeKind
CA2955294A1CanadaA1
WO2016011256A1World Intellectual Property Organization (WIPO)A1
US2016137745A1United States of AmericaA1
AU2015289613A1AustraliaA1
KR20170029613ARepublic of KoreaA
IL250080A0IsraelA0
IL250080D0IsraelD0
MX2017000627AMexicoA
EP3169353A1European Patent Office (EPO)A1
CN107206068AChinaA
JP2017528427AJapanA
RU2017104800ARussian FederationA
RU2017104800A3Russian FederationA3
ZA201700195BSouth AfricaB
EP3169353B1European Patent Office (EPO)B1
US10544232B2United States of AmericaB2
PT3169353TPortugalT
PL3169353T3PolandT3
EP3677277A1European Patent Office (EPO)A1
US2020216565A1United States of AmericaA1
ES2779402T3SpainT3
IL250080AIsraelA
IL250080BThis recordIsraelB
RU2735521C2Russian FederationC2
JP2020183439AJapanA
MX2021000898AMexicoA
AU2015289613B2AustraliaB2
AU2021204767A1AustraliaA1
US11306155B2United States of AmericaB2
JP7104108B2JapanB2
JP2022133396AJapanA
US2022315669A1United States of AmericaA1
KR20230074283ARepublic of KoreaA
KR20240017117ARepublic of KoreaA
JP7467538B2JapanB2
AU2021204767B2AustraliaB2
US2025059300A1United States of AmericaA1
MX379286BMexicoB